1. Home
  2. TRIB vs SNOA Comparison

TRIB vs SNOA Comparison

Compare TRIB & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Biotech plc

TRIB

Trinity Biotech plc

N/A

Current Price

$5.49

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

N/A

Current Price

$0.80

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRIB
SNOA
Founded
1992
1999
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
5.5M
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
TRIB
SNOA
Price
$5.49
$0.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.1K
★ 73.4K
Earning Date
12-22-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.26
EPS
★ N/A
N/A
Revenue
N/A
★ $19,529,000.00
Revenue This Year
$35.89
$22.44
Revenue Next Year
N/A
$12.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 36.68
52 Week Low
$0.28
$0.80
52 Week High
$14.17
$3.95

Technical Indicators

Market Signals
Indicator
TRIB
SNOA
Relative Strength Index (RSI) 40.72 28.04
Support Level $5.01 N/A
Resistance Level $7.45 $1.30
Average True Range (ATR) 0.58 0.10
MACD -0.03 -0.03
Stochastic Oscillator 26.22 3.29

Price Performance

Historical Comparison
TRIB
SNOA

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: